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T he Second International Research Workshop on alopecia areata was held on November 7 and 8, 1994, in Lister Hill Auditorium at the National Institutes of Health, in Bethesda, Maryland. Our knowledge of the disease has been greatly advanced since the first 
workshop , held in the same location four years ago. Important new 
findings were presented in genetic studies of alopecia areata 
including delineation of susceptibility genes and severity genes, the 
role of external and internal agents that may trigger the disease, 
anatomical targets of the follicular assault, analysis of the immune 
response, and animal models. The high caliber of the presentations 
in the setting of Lister Hill Auditorium stimulated a fervent and 
enthusiastic discussion involving all those present , approximately 
160 in all. 
This pivotal workshop brought together physicians and scientists 
from all parts of the United States, Canada, and Europe. As in the 
past, the intent was to bring alopecia areata to the awareness of a 
broad range of disciplines. The group represented those doing basic 
research and clinical research from academia to government and the 
pharmaceutical industry. In addition, families who live with alope­
cia areata were present ; for them and for all alopecia areata families, 
this gathering of scientists at the National Institutes of Health, 
sharing research results and strategizing for future research, was 
conceivably the most exciting event. 
Organizers of the Workshop were Vera H. Price, Alan N. 
Moshell, Kurt S. Stenn, Lowell A. Goldsmith , and David A. 
Norris. The Speakers, Poster Presenters, and Co-Chairs of the 
Sessions were Howard P. Baden, Wilma F. Bergfeld , Arthur P. 
Bertolino , David D. Chaplin, Beth W. Colombe , Michael J. 
Cork, John R. Couchman, Diana L. du Cros, Madeleine Duvic, 
David A. Fenton, G. Yancey Gillespie , Lowell A. Goldsmith, 
Rudolf Happle , John T. Headington , Margaret E. Hogan, Rolf 
Hoffmann, Maria K. Hordinsky, Tonja A. Kartasova, Lloyd E. 
King, Robert M. Lavker , Ulrike Lichti, Michael D. Lockshin, 
Andrew J.G. McDonagh , Kevin J. McElwee, Andrew G. Mes­
senger, Alan N. Moshell, Sigfrid A. Muller, David A. Norris, 
Michael Nutbrown, Giovanni E. Orecchia , Michael P. Philpott , 
Vera H. Price, Valerie A. Randall, Amanda J. Reynold s, Joseph 
A. Rothnagel, Marty E. Sawaya, Jerry Shapiro, Robert B. 
Skinner , Jr., Kurt S. Stenn, John P. Sundberg , Tung-Tien Sun, 
Fanny Szafer, Bruce H. Thiers, Desmond J. Tobin, Antonella 
Tosti, Arthur A. Vandenbark, and David A. Whiting. 
Dr. Michael D. Lockshin, Acting Director of the National 
Institute of Arthritis and Musculoskeletal and Skin Diseases , wel­
comed all to the meeting. The first day featured studies that were 
directly relevant to alopecia areata. The morning session included 
molecular evidence of a possible role of cytomegalic virus as a 
triggering factor, HLA studies in patients with long-standing dis­
ease and in families with alopecia areata, studies of the dermal 
papilla as a primary target , and the role of apoptosis in alopecia 
areata. The afternoon session began with Dr. Arthur Vandenbark 's 
keynote address, which was a thought-provoking review of prom­
ising emerging therapies in autoimmune diseases. This was fol-
lowed by papers on ultrastructural abnormalities in melanocytes 
and outer root sheath in alopecia areata with emphasis on changes 
in clinically unaffected scalp , studies of antibodies to the hair follicle 
in alopecia areata, and a molecular dissection of the cytokines in 
alopecia areata before and after topical immunotherapy with evi­
dence that interleukin-10 may be key in down-regulating the 
immune response. This was followed by a paper showing evidence 
that the interleuken-l receptor antagonist gene is a severity gene in 
alopecia areata, and s tudies of the mouse model of alopecia areata. 
A poignant videotape of what it means to be a child with alopecia 
areata was shown before the afternoon coffee break; this videotape 
is available through the National Alopecia Areata Foundation and 
children may take it to school to explain alopecia areata to their 
peers and teachers. 
On the evening of the first day, a lively poster session was held 
at the Bethesda Marriott, with hearty hors d'oeuvres served while 
everyone viewed the 18 posters. The posters were summarized in 
an innovative manner by designated discussers who had already had 
time to review and critique the material . The posters were grouped 
by topics that included growth factors, immunologic studies, 
histopathology, nail involvement, structure and function of cuta­
neous nerves in alopecia areata , biochemical regulation factors, 
animal models , and topical immunotherapy. 
The second day was devoted to basic hair biology studies. This 
elegant session was a showcase of the high caliber of studies in this 
field . The morning began with Dr. David Chaplin's keynote 
address on a broad overview of the entire HLA family of genes. 
This was followed by papers on current work with hair follicle stem 
cells , dermal-epidermal interactions showing hair growth from 
follicle-derived populations, a discussion of proteoglycans and 
associated proteins of the marmnalian hair follicle, alopecia in 
transgenic mice expressing mutant keratin K6 genes, hair follicle 
development and hair growth from defined cell populations grafted 
onto nude mice, cultured human hair follicles, and growth factors 
that showed the important role of insulin growth factor in hair­
cycle control. Dr. Goldsmith concluded the workshop with his able 
overview of what we had learned and recommended directions for 
future research to develop better treatments and ultimately to solve 
the mystery of alopecia areata. He underscored the need for major 
funding for continued research in this field. 
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